• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SOFAMOR DANEK USA, INC INFUSE BONE GRAFT; FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
Literature citation: norbert stiel, tim n.Hissnauer, martin rupprecht, kornelia babin, carsten w.Schlickewei, johannes m.Rueger, ralf stuecker, alexander s.Spiro, "evaluation of complications associated with off-label use of recombinant human bone morphogenetic protein-2 (rhbmp-2) in pediatric orthopaedics".Average age: 10.9 years; gender: 16 female, 23 male.(b)(4).Neither the device nor films of applicable imaging studies were returned to the manufacturer for evaluation.Therefore, we are unable to determine the definitive cause of the reported event.Although it is unknown if the device contributed to the reported event, we are filing this mdr for notification purposes.
 
Event Description
It was reported in a abstract "evaluation of complications associated with off-label use of recombinant human bone morphogenetic protein-2 (rhbmp-2) in pediatric orthopedics" that 39 patients underwent following procedures using rhbmp-2/acs: 17 patients underwent spine fusion (thoracolumbal = 9 cases; craniocervical = 5 cases; other locations = 3 cases), 11 patients underwent treatment of congenital pseudarthrosis of the tibia (7 cases) or tibial nonunion (4 cases), 5 patients underwent the management of femoral nonunion, 5 patients underwent nonunions at other locations, like the ulna (1 case), os ilium (2 cases), ankle joint (1 case), and talonavicular joint (1 case), and in 1 case for tibial shortening.Intraoperative complications were not reported.Post-op infection was reported in one case and patient underwent revision surgery.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INFUSE BONE GRAFT
Type of Device
FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Manufacturer (Section D)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer (Section G)
MEDTRONIC SOFAMOR DANEK USA, INC
4340 swinea rd
memphis TN 38118
Manufacturer Contact
greg anglin
1800 pyramid place
memphis, TN 38132
9013963133
MDR Report Key6180001
MDR Text Key62521451
Report Number1030489-2016-03434
Device Sequence Number1
Product Code NEK
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P000058
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 11/22/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/22/2016
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age10 YR
-
-